Back to Companies
TScan Therapeutics, Inc.
TCRXNasdaqCIK: 0001783328
Over the 9 most recent insider filings, TScan Therapeutics, Inc. (TCRX) has seen activity from 8 distinct insiders — all of them on the buy side. The activity is heavily weighted toward buying: $145.5K bought versus $0 sold, a net purchase of $145.5K. MacBeath Gavin is the most active by dollar volume, and the single largest transaction was $1.3M by MacBeath Gavin. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.
Total Volume
$3.0M
Purchases
$145.5K
Sales
$0
Unique Insiders
8
Recent Insider Trades
9 loaded
| May 22 | TCRX TScan Therapeutics, Inc. | Klencke Barbara | Insider | Award | $66.6K |
| May 22 | TCRX TScan Therapeutics, Inc. | Dorton Katina | Insider | Award | $66.6K |
| Jan 22 | TCRX TScan Therapeutics, Inc. | Louis Chrystal | Insider | Award | $470.4K |
| Jan 22 | TCRX TScan Therapeutics, Inc. | MacBeath Gavin | Insider | Award | $1.3M |
| Jan 22 | TCRX TScan Therapeutics, Inc. | Amello Jason | Insider | Award | $392.0K |
| Jan 22 | TCRX TScan Therapeutics, Inc. | ZDRAVESKI ZORAN | Insider | Award | $392.0K |
| Jan 22 | TCRX TScan Therapeutics, Inc. | Dworak Leiden | Insider | Award | $112.0K |
| Dec 23 | TCRX TScan Therapeutics, Inc. | Lynx1 Capital Management LP | 10% Owner | Buy | $145.5K |
| Aug 22 | TCRX TScan Therapeutics, Inc. | Dworak Leiden | Insider | Other | $0 |
9 filings